Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Pharmaceuticals Holding Co., Ltd
  6. Summary
    601607   CNE000000C82

SHANGHAI PHARMACEUTICALS HOLDING CO., LTD

(601607)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
06/11/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
21.43 21.43 20.9 20.83 20.79 Last
12872450 16966850 11566550 11128170 8373572 Volume
-1.15% 0.00% -2.47% -0.33% -0.19% Change
Financials
Sales 2021 220 B 34 057 M 34 057 M
Net income 2021 5 236 M 812 M 812 M
Net Debt 2021 26 788 M 4 152 M 4 152 M
P/E ratio 2021 12,0x
Yield 2021 2,39%
Sales 2022 245 B 37 955 M 37 955 M
Net income 2022 5 711 M 885 M 885 M
Net Debt 2022 16 124 M 2 499 M 2 499 M
P/E ratio 2022 10,5x
Yield 2022 2,75%
Capitalization 52 494 M 8 135 M 8 135 M
EV / Sales 2021 0,36x
EV / Sales 2022 0,28x
Nbr of Employees 48 136
Free-Float 61,1%
More Financials
Company
Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascular system, anti-cancer and immunoregulation, anti-infection and metabolism, as well as... 
Sector
Drug Retailers
Calendar
06/29 | 01:00am
More about the company
Ratings of Shanghai Pharmaceuticals Holding Co., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
05/27SHANGHAI PHARMACEUTICALS  : Pharma to Buy Medical Equipment Maker From Affiliate..
MT
05/27Shanghai Industrial Urban Unit to Provide Project Management Services to Shan..
MT
05/18CANSINO BIOLOGICS  : Bio, Shanghai Pharma Inject $171 Million in Additional Fund..
MT
05/12SHANGHAI PHARMACEUTICALS  : Connected transaction proposed non-public issuance o..
PU
05/12SHANGHAI PHARMACEUTICALS  : Pharma Seeks $2.2 Billion Funding from New, Existing..
MT
04/12TIANDA PHARMACEUTICALS  : Renews Sales Deal with Shanghai Pharmaceuticals
MT
04/01FISSION URANIUM  : Names New CFO
MT
01/20SHANGHAI PHARMACEUTICALS  : Strikes $9 Million Packaging Deal with Shanghai Indu..
MT
2020SHANGHAI PHARMACEUTICALS  : West China Hospital's COVID-19 vaccine candidate ent..
RE
2020Drugmakers slash prices to win China's bulk-buy contracts - state media
RE
2020SHANGHAI PHARMACEUTICALS  : Supplement announcement to the 2019 share option inc..
PU
2020SHANGHAI PHARMACEUTICALS HOLDING CO. : Ex-dividend day for final dividend
FA
2020ENZYMATICA PUBL  : signs agreement with Keyuan Trade for China
AQ
2019SHANGHAI PHARMACEUTICALS  : Grant of share options under the share option scheme
PU
2019SHANGHAI PHARMACEUTICALS  : Results of the extraordinary general meeting, a shar..
PU
More news
News in other languages on SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
2018Ardian lance la vente de l'allemand Riemser Pharma
2017SHANGHAI PHARMACEUTICALS  : Vers une cession du fabricant américain de générique..
2017Arbor courtisé par deux laboratoires chinois
2017Arbor courtisé par deux laboratoires chinois
2017Insider - Finanzinvestoren geben Stada noch nicht verloren
More news
Chart SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Duration : Period :
Shanghai Pharmaceuticals Holding Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 23,86 CNY
Last Close Price 20,79 CNY
Spread / Highest target 39,3%
Spread / Average Target 14,8%
Spread / Lowest Target -22,8%
EPS Revisions
Managers and Directors
NameTitle
Man Cho President & Executive Director
Bo Shen Chief Financial Officer, Executive Director & VP
Jun Zhou Chairman
Liang Hong Independent Non-Executive Director
Jiang Nan Cai Independent Non-Executive Director
Sector and Competitors